Trials / Completed
CompletedNCT01121315
A Retrospective Study of Cardiovascular Events Related to the Use of Glucose Lowering Drug Treatment in Primary Care
A Retrospective Epidemiological Study to Investigate Outcome and Mortality With Glucose Lowering Drug Treatment in Primary Care
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 58,326 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To describe the type II diabetes population in primary care with special reference to treatment, other diseases and mortality during the last decade. To test the hypothesis that the type or combination of per oral glucose lowering drugs have different effects on the risk of cardiovascular disease and diabetic complications.
Conditions
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2010-05-12
- Last updated
- 2012-05-11
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01121315. Inclusion in this directory is not an endorsement.